A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 69(1): 165-72, 2012 Jan.
Article
em En
| MEDLINE
| ID: mdl-21638123
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pirimidinonas
/
Benzamidas
/
Cinesinas
/
Neoplasias
Idioma:
En
Ano de publicação:
2012
Tipo de documento:
Article